Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Spectrum of pncA mutations in multidrug-resistant Mycobacterium tuberculosis isolates obtained in Latvia.

× No keyword cloud information.

11 in total

1. pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates from northwestern Russia.

Authors: H J Marttila; M Marjamäki; E Vyshnevskaya; B I Vyshnevskiy; T F Otten; A V Vasilyef; M K Viljanen
Journal: Antimicrob Agents Chemother Date: 1999-07 Impact factor: 5.191

2. Relationship between pyrazinamide resistance, loss of pyrazinamidase activity, and mutations in the pncA locus in multidrug-resistant clinical isolates of Mycobacterium tuberculosis.

Authors: M Mestdagh; P A Fonteyne; L Realini; R Rossau; G Jannes; W Mijs; K A De Smet; F Portaels; E Van den Eeckhout
Journal: Antimicrob Agents Chemother Date: 1999-09 Impact factor: 5.191

3. pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada.

Authors: S J Cheng; L Thibert; T Sanchez; L Heifets; Y Zhang
Journal: Antimicrob Agents Chemother Date: 2000-03 Impact factor: 5.191

4. Characterization of new mutations in pyrazinamide-resistant strains of Mycobacterium tuberculosis and identification of conserved regions important for the catalytic activity of the pyrazinamidase PncA.

Authors: N Lemaitre; W Sougakoff; C Truffot-Pernot; V Jarlier
Journal: Antimicrob Agents Chemother Date: 1999-07 Impact factor: 5.191

5. Pyrazinamide susceptibility and amidase activity of tubercle bacilli.

Authors: K Konno; F M Feldmann; W McDermott
Journal: Am Rev Respir Dis Date: 1967-03

6. Phenotypic characterization of pncA mutants of Mycobacterium tuberculosis.

Authors: G P Morlock; J T Crawford; W R Butler; S E Brim; D Sikes; G H Mazurek; C L Woodley; R C Cooksey
Journal: Antimicrob Agents Chemother Date: 2000-09 Impact factor: 5.191

7. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis.

Authors: A Scorpio; P Lindholm-Levy; L Heifets; R Gilman; S Siddiqi; M Cynamon; Y Zhang
Journal: Antimicrob Agents Chemother Date: 1997-03 Impact factor: 5.191

8. Mutations associated with pyrazinamide resistance in pncA of Mycobacterium tuberculosis complex organisms.

Authors: S Sreevatsan; X Pan; Y Zhang; B N Kreiswirth; J M Musser
Journal: Antimicrob Agents Chemother Date: 1997-03 Impact factor: 5.191

9. A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond. British Thoracic Society.

Authors:
Journal: Br J Dis Chest Date: 1984-10

10. Mutations in the rpoB and katG genes leading to drug resistance in Mycobacterium tuberculosis in Latvia.

Authors: T Tracevska; I Jansone; L Broka; O Marga; V Baumanis
Journal: J Clin Microbiol Date: 2002-10 Impact factor: 5.948

9 in total

Review 1. Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: a systematic review with meta-analyses.

Authors: Kwok Chiu Chang; Wing Wai Yew; Ying Zhang
Journal: Antimicrob Agents Chemother Date: 2011-07-18 Impact factor: 5.191

2. Systematic analysis of pyrazinamide-resistant spontaneous mutants and clinical isolates of Mycobacterium tuberculosis.

Authors: Karolien Stoffels; Vanessa Mathys; Maryse Fauville-Dufaux; René Wintjens; Pablo Bifani
Journal: Antimicrob Agents Chemother Date: 2012-07-23 Impact factor: 5.191

Review 3. Systematic review of mutations in pyrazinamidase associated with pyrazinamide resistance in Mycobacterium tuberculosis clinical isolates.

Authors: Sarah M Ramirez-Busby; Faramarz Valafar
Journal: Antimicrob Agents Chemother Date: 2015-06-15 Impact factor: 5.191

4. Detection by denaturing gradient gel electrophoresis of pncA mutations associated with pyrazinamide resistance in Mycobacterium tuberculosis isolates from the United States-Mexico border region.

Authors: Mark T McCammon; John S Gillette; Derek P Thomas; Srinivas V Ramaswamy; Ishmael I Rosas; Edward A Graviss; Jan Vijg; Teresa N Quitugua
Journal: Antimicrob Agents Chemother Date: 2005-06 Impact factor: 5.191

5. Peruvian and globally reported amino acid substitutions on the Mycobacterium tuberculosis pyrazinamidase suggest a conserved pattern of mutations associated to pyrazinamide resistance.

Authors: Mirko Zimic; Patricia Sheen; Miguel Quiliano; Andrés Gutierrez; Robert H Gilman
Journal: Infect Genet Evol Date: 2009-12-04 Impact factor: 3.342

6. Rapid colorimetric testing for pyrazinamide susceptibility of M. tuberculosis by a PCR-based in-vitro synthesized pyrazinamidase method.

Authors: Man Zhou; Xuelei Geng; Jun Chen; Xude Wang; Dianbing Wang; Jiaoyu Deng; Zhiping Zhang; Weihua Wang; Xian-En Zhang; Hongping Wei
Journal: PLoS One Date: 2011-11-10 Impact factor: 3.240

7. Novel Mutations in pncA Gene of Pyrazinamide Resistant Clinical Isolates of Mycobacterium tuberculosis.

Authors: Manijeh Kahbazi; Hossein Sarmadian; Azam Ahmadi; Farshideh Didgar; Maryam Sadrnia; Toktam Poolad; Mohammad Arjomandzadegan
Journal: Sci Pharm Date: 2018-04-16

Review 8. A Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta-Analysis.

Authors: Michael G Whitfield; Heidi M Soeters; Robin M Warren; Talita York; Samantha L Sampson; Elizabeth M Streicher; Paul D van Helden; Annelies van Rie
Journal: PLoS One Date: 2015-07-28 Impact factor: 3.240

9. High prevalence of phenotypic pyrazinamide resistance and its association with pncA gene mutations in Mycobacterium tuberculosis isolates from Uganda.

Authors: Resty Naluyange; Gerald Mboowa; Kevin Komakech; Derrick Semugenze; David Patrick Kateete; Willy Ssengooba
Journal: PLoS One Date: 2020-05-15 Impact factor: 3.240

9 in total